Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer.
Cancers (Basel). 2022 Feb 28;14(5):1252. doi: 10.3390/cancers14051252.
Cancers (Basel). 2022.
PMID: 35267560
Free PMC article.
Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient.
Meijer TG, Martens JWM, Prager-van der Smissen WJC, Verkaik NS, Beaufort CM, van Herk S, Robert-Finestra T, Hoogenboezem RM, Ruigrok-Ritstier K, Paul MW, Gribnau J, Bindels EMJ, Kanaar R, Jager A, van Gent DC, Hollestelle A.
Meijer TG, et al.
Cancers (Basel). 2024 Feb 10;16(4):741. doi: 10.3390/cancers16040741.
Cancers (Basel). 2024.
PMID: 38398132
Free PMC article.
Item in Clipboard
Cite
Cite